Treating Retinal Vein Occlusion with Infrared Light Therapy
Retinal Vein Occlusion (RVO) is a vascular disorder characterized by the blockage of one of the veins that carry blood away from the retina. There are two main types of RVO: Central Retinal Vein Occlusion (CRVO) and Branch Retinal Vein Occlusion (BRVO). CRVO occurs when the central vein of the retina is blocked, leading to widespread retinal swelling and bleeding. BRVO, on the other hand, involves the blockage of one of the branch veins, causing localized retinal hemorrhages and edema.
Diagnosis of RVO typically involves a comprehensive eye examination, including fundoscopy to assess the retinal blood vessels, optical coherence tomography (OCT) to evaluate retinal thickness and morphology, and fluorescein angiography to visualize blood flow in the retinal vessels.
While RVO is primarily considered a vascular disorder, it can also lead to secondary complications such as glaucoma. Increased intraocular pressure resulting from retinal ischemia and inflammation may damage the optic nerve, leading to glaucomatous optic neuropathy. Glaucoma is a group of eye conditions characterized by damage to the optic nerve, often associated with elevated intraocular pressure.
The Retyne Infrared Eye treatment mask can assist in the management of RVO symptoms through the use of program #2 on the Retyne controller. This program utilizes invisible infrared light therapy to improve blood circulation, reduce inflammation, and alleviate symptoms associated with RVO. By targeting the affected retinal tissue with specific frequencies, the Retyne mask aims to promote healing and reduce the risk of complications such as glaucoma.
Infrared light therapy has been shown to enhance tissue repair, reduce edema, and improve blood flow in ocular tissues. By delivering targeted infrared light therapy to the affected retina, the Retyne mask can help alleviate symptoms such as vision loss, retinal hemorrhages, and macular edema associated with RVO.
Retinal Vein Occlusion is a vascular disorder that can lead to vision loss and secondary complications such as glaucoma. The Retyne Infrared Eye treatment mask offers a non-invasive therapeutic approach to managing RVO symptoms by utilizing invisible infrared light therapy. Through program #2 on the Retyne controller, this treatment aims to improve blood circulation, reduce inflammation, and promote healing in the affected retinal tissue, ultimately enhancing visual outcomes for individuals with RVO.
The Retyne eye treatment mask utilizes a general selection of frequencies (0.07, 0.12, 0.6, 0.87, 2.25, 22.5, 187.5, 396.5, 587.5, 696.5) tailored to address the symptoms related to Retinal Vein Occlusion. These frequencies have been meticulously chosen for their proven effectiveness in managing and treating this visual condition.
Retyne's approach involves converting each frequency into invisible infrared light output, marking a groundbreaking fusion of frequencies with light—a pioneering technology pioneered by Retyne Labs. Inspired by the groundbreaking work of Dr. Rife, who identified healing properties in specific frequencies and utilized light for their transmission, Retyne's innovative method capitalizes on current research on invisible infrared technology and builds upon past studies on light transmission through frequency sources. The result is the Retyne eye Treatment Mask, a convergence of state-of-the-art advancements in the field of visual care.
Moreover, for those utilizing advanced hardware such as the RDPV4, a secondary set of alternate frequencies for Retinal Vein Occlusion: 0.44, 0.6, 0.85, 5.09, 7.25, 92.5, 337.3, 476.5, 527, 663.71 is available. The RDPv4 offers an expanded range of frequencies, finely calibrated to provide even greater precision in addressing this eye disorder. By incorporating this secondary set of frequencies, the RDPV4 elevates the potential therapeutic benefits of the Retyne eye Treatment Mask, catering to individuals seeking advanced solutions for their visual health needs.
A Retinal Vein Occlusion Compatibile group exists at program 1407: (0.07, 0.12, 0.6, 0.87, 2.25, 22.5, 187.5, 396.5, 587.5, 696.5)
A Retinal Vein Occlusion Alternate group exists at program 2952 Retinal Vein Occlusion: 0.15, 0.18, 0.8, 5.5, 33.2, 172.3, 471.2, 557.82, 603.44, 921.88
Compatibility
Standalone controller (Program #2) (Controller shipped with Retyne Eye Treatment Mask)
RDPV4 (Direct connect, use group 2952)
RDPV4 Light Mask Program button 2
Click here for instructions on using the Retyne Mask + Controller
